Lv1
50 积分 2024-08-25 加入
Sustained benefit of zanubrutinib vs ibrutinib in patients with R/R CLL/SLL: final comparative analysis of ALPINE
5个月前
已完结
Incidence and associated risk factors for invasive fungal infections and other serious infections in patients on ibrutinib
5个月前
已关闭
The novel Bruton tyrosine kinase inhibitor branebrutinib abrogates lipopolysaccharide/galactosamine-induced hepatic injury via limiting inflammation and oxidative stress
6个月前
已完结
Dual biological role and clinical impact of de novo chromatin activation in chronic lymphocytic leukemia
9个月前
已关闭
8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation
10个月前
已完结
Targeting the Immune Microenvironment in Chronic Lymphocytic Leukemia: An Evolving Therapeutic Strategy
10个月前
已完结
Fungal infection in patients treated with Bruton's Tyrosine Kinase inhibitor, from epidemiology to clinical outcome: A systematic review
10个月前
已完结
[Analysis of infection in B-cell lymphoma patients treated with BTK inhibitors]
10个月前
已关闭
皖公网安备34019202002308
